5 active warrant series covering 23,372,006 shares (~28.5% potential dilution); nearest expiry 2027-06-06.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.25 | Jun 6, 2027 249d | 883K | OTM | 1.1% | C$221K | Auto |
| warrant | $0.30 | Aug 25, 2027 329d | 334K | OTM | 0.4% | C$100K | Auto |
| warrant | $1.00 | Sep 22, 2027 357d | 1.3M | OTM | 1.6% | C$1.3M | Auto |
| warrant | $0.50 | Feb 19, 2028 507d | 17.0M | OTM | 20.7% | C$8.5M | Auto |
| warrant | $0.30 | Aug 25, 2028 695d | 3.9M | OTM | 4.7% | C$1.2M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
7 option grants covering 5,423,200 shares (~6.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.50 | Apr 14, 2027 196d | 285K | OTM | 0.3% | C$143K | Auto |
| option | $2.20 | Jun 13, 2028 622d | 50K | OTM | 0.1% | C$110K | Auto |
| option | $0.60 | Mar 14, 2029 896d | 798K | OTM | 1.0% | C$479K | Auto |
| option | $0.16 | Jun 23, 2030 1362d | 2.5M | OTM | 3.0% | C$395K | Auto |
| option | $0.25 | Jan 21, 2031 1574d | 150K | OTM | 0.2% | C$38K | Auto |
| option | $0.47 | Mar 3, 2031 1615d | 1.4M | OTM | 1.7% | C$644K | Auto |
| option | $0.72 | May 25, 2031 1698d | 300K | OTM | 0.4% | C$216K | Auto |
82,015,738 shares outstanding, plus 23,372,006 from warrants and 5,423,200 from options — a fully diluted 110,810,944 shares, or ~35.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
5 active warrant series covering 23,372,006 shares (~28.5% potential dilution); nearest expiry 2027-06-06.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.25 | Jun 6, 2027 249d | 883K | OTM | 1.1% | C$221K | Auto |
| warrant | $0.30 | Aug 25, 2027 329d | 334K | OTM | 0.4% | C$100K | Auto |
| warrant | $1.00 | Sep 22, 2027 357d | 1.3M | OTM | 1.6% | C$1.3M | Auto |
| warrant | $0.50 | Feb 19, 2028 507d | 17.0M | OTM | 20.7% | C$8.5M | Auto |
| warrant | $0.30 | Aug 25, 2028 695d | 3.9M | OTM | 4.7% | C$1.2M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
7 option grants covering 5,423,200 shares (~6.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.50 | Apr 14, 2027 196d | 285K | OTM | 0.3% | C$143K | Auto |
| option | $2.20 | Jun 13, 2028 622d | 50K | OTM | 0.1% | C$110K | Auto |
| option | $0.60 | Mar 14, 2029 896d | 798K | OTM | 1.0% | C$479K | Auto |
| option | $0.16 | Jun 23, 2030 1362d | 2.5M | OTM | 3.0% | C$395K | Auto |
| option | $0.25 | Jan 21, 2031 1574d | 150K | OTM | 0.2% | C$38K | Auto |
| option | $0.47 | Mar 3, 2031 1615d | 1.4M | OTM | 1.7% | C$644K | Auto |
| option | $0.72 | May 25, 2031 1698d | 300K | OTM | 0.4% | C$216K | Auto |
82,015,738 shares outstanding, plus 23,372,006 from warrants and 5,423,200 from options — a fully diluted 110,810,944 shares, or ~35.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
